תוצאות חיפוש - Alicja Hubalewska-Dydejczyk

Development of the ^99mTc-Labelled SST₂ Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study מאת Doroteja Novak, Barbara Janota, Anton Amadeus Hörmann, Agnieszka Sawicka, Marko Kroselj, Alicja Hubalewska-Dydejczyk, Melpomeni Fani, Renata Mikolajczak, Petra Kolenc, Clemens Decristoforo, Piotr Garnuszek

Connect to this object online.

Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutriti... מאת Aleksandra Gilis-Januszewska, Jaana Lindström, Jaakko Tuomilehto, Beata Piwońska-Solska, Roman Topór-Mądry, Zbigniew Szybiński, Markku Peltonen, Peter E. H. Schwarz, Adam Windak, Alicja Hubalewska-Dydejczyk

Connect to this object online.

Determinants of weight outcomes in type 2 diabetes prevention intervention in primary health care setting (the DE-PLAN project) מאת Aleksandra Gilis-Januszewska, Beata Piwońska-Solska, Jaana Lindström, Ewa Wójtowicz, Jaakko Tuomilehto, Peter E. H. Schwarz, Katarzyna Kissimova-Skarbek, Zbigniew Szybiński, Adam Windak, Alicja Hubalewska-Dydejczyk

Connect to this object online.

Selection of the First ^99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates מאת Melpomeni Fani, Viktoria Weingaertner, Petra Kolenc Peitl, Rosalba Mansi, Raghuvir H. Gaonkar, Piotr Garnuszek, Renata Mikolajczak, Doroteja Novak, Urban Simoncic, Alicja Hubalewska-Dydejczyk, Christine Rangger, Piriya Kaeopookum, Clemens Decristoforo

Connect to this object online.